Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

PA

US expert panel recommends approval of Pfizer's Covid-19 vaccine

A final FDA decision is expected within days.

LAST UPDATE | 10 Dec 2020

A US GOVERNMENT advisory panel has endorsed Pfizer’s coronavirus vaccine in a major step towards a massive vaccination campaign that could finally conquer the outbreak.

The Food and Drug Administration is expected to follow the recommendation issued today by its expert advisers.

The advisory group, in a 17-4 vote with one abstention, concluded that the vaccine appears safe and effective against the coronavirus in people aged 16 and older.

health-coronavirus Press Association Images Press Association Images

A final FDA decision is expected within days.

Millions of shots would then be shipped to begin vaccinating health care workers and nursing home residents.

Widespread access to the general public is not expected until the spring.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Author
Nora Creamer
View 37 comments
Close
37 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds